Search results
Added:
1 year ago
AHA Conference 2024 - In this highlights video from AHA 2024, Dr Michelle Kittleson (Cedars-Sinai California Heart Center, US) offers a concise and insightful summary of the most influential late-breaking trials presented at the conference. Dr Kittleson discusses the pivotal studies poised to impact clinical practice and enhance patient outcomes in heart failure care.Trials covered in detail…
View more
Added:
1 year ago
In this Meet the Experts session, from e-SPACE Heart Failure 2024, Prof Andrew Coats and Dr Patricia Campbell engage in an in-depth discussion on SGLT2 inhibitors, focusing on their real-world application in clinical practice.
View more
Start date:
Sep 10, 2024
Learn from your interventional, imaging and heart failure colleagues about the latest in recognizing and treating patients with mitral and tricuspid valve disease. Participate in case-based discussions, brush up on the latest clinical data and guidelines and learn more about new approved technologies for your valvular disease patients. We hope you can join us for this engaging and interactive…
View more
Added:
1 year ago
HFSA 2024 - We are joined by Dr Ambarish Pandey (University of Texas Southwestern Medical Center, US) to discuss the findings from HuMAIN HFpEF, a phase 2A randomized, parallel-group, placebo-controlled study of HU6 in patients with obesity and heart failure with preserved ejection fraction (HFpEF).Interview Questions:What is the reasoning behind this study?Could you tell us about the mechanism…
View more
Added:
1 year ago
AHA Conference 2024 — New insights into the SUMMIT trial, investigating tirzepatide in patients with heart failure with preserved ejection fraction (HFpEF) and obesity.Dr Harriette Van Spall (McMaster University, CA) is joined by Dr Milton Packer (Baylor Heart and Vascular Institute, US) to discuss the findings from the randomized, double-blind, phase 3 SUMMIT trial (NCT04847557) investigating…
View more
Clinical Clues in Cardiovascular Disease
Video Series
Added:
1 year ago
HFSA 24 - We are joined virtually by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss findings from the STEP-HFpEF trial programme in regard to the efficacy of semaglutide according to frailty status, and exercise function at baseline.Interview Questions:1. Could you remind us of the importance of STEP-HFpEF2. What was the study design and patient population?3. What…
View more
Start date:
Nov 26, 2024
Join Dr Pugazhendhi Vijayaraman (Geisinger Heart Institute, US), Prof Rajeev Pathak (Australian National University, AU) and Dr Matthew Bernabei (Lancaster General Hospital, US) as they explore conduction system pacing (CSP) as an evolving approach in cardiac care.They offer a comprehensive view of the current landscape of CSP, share insights from real-world case studies, present a critical…
View more
Added:
4 months ago
Explore the diagnostic and therapeutic complexities of cardiac sarcoidosis with Prof Emer Joyce.This presentation, part of the comprehensive Cardiomyopathies track, tackles the persistent challenges in cardiac sarcoidosis, emphasizing that despite decades of clinical experience, diagnosis remains the field's greatest hurdle.Prof Joyce explores the heterogeneous clinical phenotypes capable of…
View more
Theresa A McDonagh
Research Area(s) / Expertise:
Job title: Professor of Heart Failure and Consultant Cardiologist
Author